Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | CCR1 | P32246 | 3/20 | 0.63 |
| ▸ | CCR5 | P51681 | 3/20 | 0.63 |
| ▸ | CCR8 | P51685 | 3/20 | 0.63 |
| ▸ | TP53 | P04637 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | ALPL | P05186 | 1/20 | 0.63 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.63 |
| ▸ | ALPI | P09923 | 1/20 | 0.63 |
| ▸ | ALPG | P10696 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | METAP1 | P53582 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL28311873 | 0.93 | KDM4E (0.55) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL14297293 | 0.86 | CTSS (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29988787 | 0.85 | CTSS (0.55) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL9220648 | 0.85 | CTSS (0.55) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL1771966 | 0.83 | CTSS (0.53) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL30615716 | 0.82 | KDM4E (0.47) | KDM4ELMNACCR1CCR5CCR8 | |
| Terpyridine SCHEMBL30610399 | 0.81 | KDM4E (0.95) | KDM4ELMNACCR1CCR5CCR8 | |
| Terpyridine SCHEMBL30610400 | 0.81 | KDM4E (0.95) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL15819400 | 0.81 | KDM4E (0.63) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL31754524 | 0.80 | KDM4E (0.48) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | claimed |
| EP-4473309-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2024-12-11 | — | — | EP | claimed |
| CN-119013558-A | Photoactivated antibody conjugates | 新析生物科技股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2023196986-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2023-10-12 | — | — | WO | claimed |
| CN-113713858-B | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2023-06-23 | — | — | CN | claimed |
| US-20230167144-A1 | PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION | Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) | 2023-06-01 | — | — | US | claimed |
| CN-113713858-A | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2021-11-30 | — | — | CN | claimed |
| CN-113559939-A | Alpha alkylation reaction catalyst for nitrile and preparation method thereof | 郑州大学 | 2021-10-29 | — | — | CN | claimed |
| CN-111518145-A | Cyanide-bridged metal organic compound with intramolecular magnetic transformation, and preparation method and application thereof | 荆楚理工学院 | 2020-08-11 | — | — | CN | claimed |
| CN-110003284-A | Containing asymmetric pincerlike ruthenium compound of pyridine-pyridine-benzenesulfonyl imidazoline and preparation method thereof | 郑州大学 | 2019-07-12 | — | — | CN | claimed |
| EP-2868661-B1 | BIPYRIDYL TRIAZOLE RARE EARTH COMPLEX AND PREPARATION PROCESS THEREFOR | GUANGDONG SYNYOO NEW MATERIAL CO LTD (CN) | 2016-11-09 | — | — | EP | claimed |
| EP-2868661-A1 | BIPYRIDYL TRIAZOLE RARE EARTH COMPLEX AND PREPARATION PROCESS THEREFOR | Guangdong Synyoo New Material Co. Ltd. (CN) | 2015-05-06 | — | — | EP | claimed |
| US-8853399-B1 | Bipyridine triazole type rare earth complex and preparation method thereof | GUANGDONG SYNYOO NEW MATERIAL CO., LTD. (CN) | 2014-10-07 | — | — | US | claimed |
| US-20140288305-A1 | BIPYRIDINE TRIAZOLE TYPE RARE EARTH COMPLEX AND PREPARATION METHOD THEREOF | GUANGDONG SYNYOO NEW MATERIAL CO., LTD. (CN) | 2014-09-25 | — | — | US | claimed |
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | disclosed |
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| CN-119039358-B | Lattice type iron-based complex based on cis-trans-isomerism triazole and preparation method thereof | 西北工业大学 | 2025-02-18 | — | — | CN | disclosed |
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-02-10 | — | — | US | disclosed |
| EP-1424336-A1 | 1,3-BENZOTHIAZINONE DERIVATIVES AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-06-02 | — | — | EP | disclosed |
| EP-0850322-B1 | SELECTIVE SEPARATION OF DISSOLVED METAL SPECIES WITH SUBSTITUTED 1,3,5 TRIAZINE EXTRACTANTS | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2001-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288305-A1 | BIPYRIDINE TRIAZOLE TYPE RARE EARTH COMPLEX AND PREPARATION METHOD THEREOF | LAS1L, RUVBL1, PDCD2L | KDM4E 3902/4885LMNA 1357/4885CCR1 3156/4885 |
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | MIF, MORF4L1, FOXM1 | KDM4E 3627/4885LMNA 1854/4885CCR1 199/4885 |
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | KDM4E 4590/4885LMNA 674/4885CCR1 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.